Yiqun Fang

Prof. Dr. Yiqun Fang


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
JSJing Shi
Jing Shi
YLYabin Li
Yabin Li
HZHouyu Zhao
Houyu Zhao
CYChenyang Yan
Chenyang Yan
RCruxia Cui
ruxia Cui
YFYiqun Fang
Yiqun Fang
In recent years, the role played by exosomes in lung diseases has been investigated. Exosomes have been shown to contribute to reductions in lung inflammation and pulmonary fibrosis. However, the role played by exosomes in pulmonary oxygen toxicity and the mechanism involved have not yet been reported. In the present work, we aimed to investigate the mechanism by which stem cell exosomes protect lung tissue and the potential molecular regulatory network involved. In this study, we employed single-cell RNA sequencing techniques to elucidate the unique cellular and molecular mechanisms underlying the progression of exosome therapy for pulmonary oxygen toxicity. We found changes in cell populations after exosome treatment, characterized by the expression of different molecular markers. We also integrated single-cell RNA sequencing (scRNA-seq) and bulk analysis to identify the protective effects of mesenchymal stem cell exosomes (MSC-Exos) in a mouse pulmonary oxygen toxicity (POT) model. scRNA-seq revealed dynamic shifts in the lung cellular composition after exosome treatment, including a reduction in inflammatory lymphoid cells (NK, B cells, CD8+ T, CD4+ T) and restored alveolar epithelial populations (AT1/AT2). A comprehensive gene expression analysis showed that inflammatory pathways associated with oxidative stress were significantly upregulated. In addition, our analysis of the intercellular interaction network revealed that there was a significant reduction in intercellular signal transduction in the POT group compared to the exosome-treated group. These results not only shed light on the unique cellular heterogeneity and potential pathogenesis following exosome therapy, but they also deepen our understanding of molecular pathophysiology and provide new avenues for targeted therapeutic strategies.

Verified
Journal Article
Open access
PDF file
JSJing Shi
Jing Shi
HZHouyu Zhao
Houyu Zhao
CYChenyang Yan
Chenyang Yan
PZPing Zhu
Ping Zhu
QZQi Zhu
Qi Zhu
YFYiqun Fang
Yiqun Fang
Acute lung injury (ALI) is in part precipitated by hyperbaric oxygen or other mechanical insults. It constitutes the fundamental pathological process underlying acute respiratory distress syndrome (ARDS). The manifestation of the condition is characterized by an uncontrolled inflammatory response and alveolar edema, consequent to the disruption of the alveolar–capillary barrier. This phenomenon is associated with elevated morbidity and mortality rates. The current therapeutic interventions for ALI are not well researched or articulated. However, recent studies have indicated that stem cells may possess therapeutic potential in the context of ALI. The present study demonstrates that these exosome preparations have the capacity to significantly ameliorate radiographic findings, histological parameters, and vascular permeability in murine models of ALI. Concurrently, they attenuate the inflammatory response to a certain extent. The present review commences with an examination of the pathogenic mechanisms and manifestations of pulmonary injury induced by hyperbaric oxygen or other external factors. The subsequent sections of the text provide detailed accounts of the latest advances in exosome-based therapies for mitigating such injury, including their mechanisms of action and future translational prospects. While exosome-based treatments have demonstrated considerable advancement in preclinical research, numerous challenges must be surmounted before their widespread implementation in clinical settings can be realized, underscoring the necessity for sustained research in this domain.

Verified
Journal Article
Open access
PDF file
WDWei Ding
Wei Ding
QZQi Zhu
Qi Zhu
HZHouyu Zhao
Houyu Zhao
Guanning WeiGuanning Wei
Guanning Wei
GHGuoyang Huang
Guoyang Huang
YFYiqun Fang
Yiqun Fang
Central nervous system oxygen toxicity (CNS-OT) is a major complication of hyperbaric oxygen (HBO) characterized by seizures and neuronal damage, yet the underlying mechanisms remain incompletely understood. Using male Sprague Dawley rats (n = 6 per group) and HT22 neurons exposed to either HBO (6 ATA, 100% O2) or hyperbaric normoxia (HNO), our results demonstrate that HBO, but not HNO, caused mitochondrial structural damage and loss of mitochondrial membrane potential (ΔΨm). Transcriptomic analysis revealed enrichment of apoptosis and mitogen-activated protein kinase (MAPK) signaling pathways. Using HeLa cells stably overexpressing Parkin and Mito-Keima, a pH-sensitive mitochondrial probe system for monitoring mitophagy, we observed that mitophagic flux was initiated but proceeded too slowly to clear damaged mitochondria in a timely manner in HBO-exposed neurons. Pharmacological preconditioning to activate mitophagy enabled the prompt elimination of dysfunctional mitochondria and rescued HBO-induced mitochondrial dysfunction and cell death. In vivo, everolimus treatment promoted timely mitophagic clearance, prolonged seizure latency, attenuated ΔΨm loss, and suppressed p-p38 activation. These findings demonstrate that HBO exposure disrupts mitochondrial homeostasis and activates pro-apoptotic MAPK signaling. Meanwhile, endogenous mitophagy is initiated but fails to clear damaged mitochondria in a timely manner. Pre-activation of mitophagy by everolimus enables the timely clearance of damaged mitochondria, protecting against CNS-OT and highlighting a promising therapeutic strategy.